01-09-2005 | ORIGINAL CONTRIBUTION
Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS® MPH
Results of a 3-week open-label study
Published in: European Child & Adolescent Psychiatry | Issue 6/2005
Login to get access